Clinical Trials Directory

Trials / Terminated

TerminatedNCT01751139

An Epidemiological Surveillance Study to Evaluate the Incidence of Dengue in Brazil

An Epidemiological Surveillance Study to Evaluate the Incidence of Dengue in Endemic Regions of Brazil

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
3,300 (actual)
Sponsor
GlaxoSmithKline · Industry
Sex
All
Age
6 Months
Healthy volunteers
Accepted

Summary

The purpose of this study is to estimate the incidence of dengue infection in children and adults in geographically distinct locations of Brazil.

Detailed description

The aim of this study is to generate dengue disease burden data including estimates of incidence rates, prevalence data and the clinical presentation of dengue across different age groups. The study will be conducted in at least three cities: Rio de Janeiro, Salvador, and Manaus. This study will also prepare potential sites for future clinical trials, by setting up the logistics and training staff on site to enroll a cohort of subjects perform dengue surveillance and other study procedures. Households will be randomly selected from communities where a registry system is implemented. All individuals in the household will be eligible for participating in the study. This study will be sponsored by GSK and co-funded by GSK and Fiocruz. As study sponsor, GSK will delegate some activities to Fiocruz, according to the provisions in their Cooperative Research and Development Agreement (CRADA).

Conditions

Interventions

TypeNameDescription
PROCEDUREBlood sample collectionBlood samples will be collected at each study visit (Day 0, Month 6, Month 12, Month 24, Month 36 and Month 48) and any time during the study that dengue is suspected. Samples collected at scheduled visits will be tested for anti-dengue antibodies. Samples collected at visits for dengue suspicion will be tested for dengue infection diagnosis.
OTHERData collectionDiary logs will be issued to all subjects at every visit, except Month 48 (Day 0, Month 6, Month 12, Month 24, and Month 36), as required. Any completed diary logs will be verified, as applicable. Subjects will be given a diary log in the event of the occurrence of a symptom that may be associated with suspected dengue.

Timeline

Start date
2014-02-18
Primary completion
2018-12-20
Completion
2018-12-20
First posted
2012-12-17
Last updated
2020-04-27
Results posted
2020-03-26

Locations

5 sites across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01751139. Inclusion in this directory is not an endorsement.